Latest news with #QX
Local Sweden
30-04-2025
- Business
- Local Sweden
Sweden 'would be totally up for inviting in 40,000 Hungarian gays'
Swedish trade minister Benjamin Dousa has called for Sweden to strengthen its image as an "open and freedom-loving country" which welcomes foreigners who want to start businesses or develop their careers, throwing out a welcome mat to victims of Hungary's Pride ban. Advertisement During a panel discussion held as part of the publication of the Swedish Institute's new strategy to boost Sweden's image, he burst out: "We'd be totally up for inviting in 40,000 Hungarian gays". "It's just this idea about Sweden as an open country," he told QX magazine of the joke, a nod to a famous prank call mounted by the comedian Fredrik Lindström during Sweden's EU membership referendum campaign. "There are several countries that are moving in a more authoritarian direction. There are more countries that are raising tariffs and shutting themselves off," he continued. "It's not a development that an open and freedom-loving country like Sweden wants to see. We are open to people coming here regardless of whether they want to work here, start a business here, raise a family here, or invest in Sweden." The Swedish Institute on Tuesday reported the results of a national drive it has led on the orders of the government to "strengthen Sweden's international competitiveness, create trust and increase resilience against misleading information about Sweden". As part of the drive, more than 300 organisations – including business, higher education, government agencies, and civil society groups – have provided suggestions on how to boost the image of Sweden internationally. The result is a strategy that builds on Sweden's existing image of a well-governed country with a strong welfare state. Advertisement "People across the world associate our country with equality, high quality of life and the green transition," the report reads. "Let's demonstrate the value of freedom, equality, and cooperation at a time when worryingly many others are pushing in the other direction, and at the same time boost Sweden's competitiveness." The new strategy, which Dousa was attending the launch of, aims to sell Sweden as a country that "gives room to grow", with a strong democracy providing the foundation for a culture based around "reliability" and "creativity" and a "willingness to cooperate", which in turn leads to a business and social environment where people and companies can grow, leading in turn to an innovative society. Sweden did not want to just recruit people from countries like Hungary, where the government in March banned LGBT Pride marches, Dousa said, but also from the US, where the worsening climate for business, immigrants and academic freedom could produce opportunities for Sweden. "The same applies to the US," he said. "40,000 top talents from tech companies and universities are welcome to come to Sweden. We are working very intensively to attract that type of immigration to Sweden. We have reduced the processing times from around 100 days to just over two weeks." Dousa said that Lars Strannegård, President of the Stockholm School of Economics, had told him that he believed Sweden was in a good position to attract promising researchers from the US who were near the start of their careers. Advertisement "Those who have perhaps just completed their doctorate," he said. "What Sweden offers is a combination of academic excellence and an innovative business community together with the softer values associated with being one of the most innovative, tolerant countries in the world." READ ALSO: 'Never waste a good crisis': How Sweden wants to attract US talent fleeing Trump
Yahoo
13-02-2025
- Business
- Yahoo
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
Transaction To Complement Bio-Rad's Existing Digital PCR Portfolio and Accelerate Development of Next-Generation Digital PCR Solutions HERCULES, Calif., February 13, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to purchase all equity interests in Stilla Technologies ("Stilla"). The acquisition remains subject to consultation with relevant employee representatives, regulatory approvals, and other customary closing conditions, and is expected to close by the end of the third quarter of 2025. With operations in France and the U.S., Stilla develops and markets next-generation digital PCR instruments, consumables, and assays. The company's Nio® family of all-in-one digital PCR systems aids the development of a wide range of genetic tests and molecular assays across multiple applications including liquid biopsy for oncology diagnostics, cell and gene therapy, organ transplant testing, infectious diseases, and food and environmental testing. "Stilla's next-generation digital PCR solutions would make a compelling and complementary addition to Bio-Rad's best-in-class digital PCR portfolio," said Norman Schwartz, CEO of Bio-Rad Laboratories. "Once closed, the acquisition will support our strategy to further expand our business into applied research and clinical diagnostics where customers expect a higher degree of automation and throughput capabilities." Jim Barry, EVP and President of Bio-Rad's Life Science Group, added, "Together with our planned launch of Bio-Rad's QX Continuum™ system, the Stilla platform would allow us to serve the full range of digital PCR applications and help us meet the evolving needs of customers in genomics research and applied science." Rémi Dangla, CEO of Stilla Technologies, stated, "We are thrilled with the prospect of joining Bio-Rad, a leader in the field of digital PCR. With Stilla's passion for product development and Bio-Rad's extensive life science expertise, operational excellence, and global reach, together we can bring substantial value to the work of applied research and biopharma customers around the globe." BIO-RAD and QX Continuum are trademarks of Bio-Rad Laboratories, Inc., Nio is a trademark of Stilla Technologies SAS. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit Bio-Rad Forward-Looking Statements This release may be deemed to contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements we make regarding our offer to acquire Stilla Technologies. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "plan", "believe," "expect," "anticipate," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions, although not all forward-looking statements contain these words. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. These risks and uncertainties include, but are not limited to, the timing of the proposed transaction; the possibility that various conditions to the consummation of the proposed transaction may not be satisfied or waived; the ability to obtain necessary regulatory approvals or to obtain them on acceptable terms or within expected timing; the effects of disruption from the proposed transaction and the impact of the announcement and pendency of the proposed transaction on Stilla Technologies' business; the possibility that the anticipated benefits from the proposed transaction cannot be realized in the manner contemplated; the ability to successfully integrate the acquired business into the Company's operations; the planned launch of our QX Continuum system; and other factors beyond the control of the Company and/or Stilla Technologies. For further information regarding our risks and uncertainties, please refer to the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operation" in Bio-Rad's public reports filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Bio-Rad cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. We disclaim any obligation to update these forward-looking statements. View source version on Contacts Bio-Rad Investor Contact: Edward Chung, Investor Relations510-741-6104ir@ Bio-Rad Media Contact: Anna Gralinska, Corporate Communications510-741-6643cc@ Sign in to access your portfolio
